Reports
Global Obsessive-Compulsive Disorder Drugs Market: By Product: SSRI, TCA, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand, EMR’s Key Indicators for Price; Competitive Landscape; Industry Events and Developments
Global Obsessive-Compulsive Disorder Drugs Market Outlook
The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2023-2028.
The global obsessive-compulsive disorder drugs market is being driven by the rising investment in R&D and health care sector, the rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Properties and Applications
Obsessive-compulsive disorder (OCD) is a medical condition characterised by unreasonable thoughts and obsessions or fears, which leads to compulsive behaviour in an individual. Antidepressants are often the first medications prescribed to treat OCD.
The global obsessive-compulsive disorder drugs market can be divided on the basis of segments like products and regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
- Product:
- SSRI
- TCA
- Others
The EMR report looks into the regional obsessive-compulsive disorder drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The development of new drugs to treat the obsessive-compulsive disorder is one of the major factors driving the growth of the industry globally. With rising consumer awareness, the demand for drugs with enhanced bioavailability, safety, and dosage parameters has increased, leading manufacturers to focus on the R&D of new OCD drugs. Thus, the launch of these products is expected to aid the growth of the obsessive-compulsive disorder drugs industry over the forecast period. Further, the growing acceptance of off-label drugs in combination with the approved therapies is providing a boost to the industry.
The SSRI segment, among other product types, dominated the industry in 2020, owing to the presence of several SSRIs including fluoxetine, fluvoxamine, paroxetine, and others, coupled with their fewer side effects in comparison to other drug types. Further, North America accounted for the largest share in the industry in 2020 due to the rising prevalence of obsessive-compulsive disorder and increased government initiatives in the region to combat this condition. The region is expected to dominate the obsessive-compulsive disorder drugs market in the forecast period as well.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global obsessive-compulsive disorder drugs industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Eli Lilly and Company
- GlaxoSmithKline plc
- H. Lundbeck A/S
- Pfizer Inc.
- Lupin Limited
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Region |
| Breakup by Product | SSRI, TCA, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Eli Lilly and Company, GlaxoSmithKline plc, Lupin, and Pfizer Inc., among others. |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Obsessive-Compulsive Disorder Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Obsessive-Compulsive Disorder Drugs Historical Market (2018-2022)
8.3 Global Obsessive-Compulsive Disorder Drugs Market Forecast (2023-2028)
8.4 Global Obsessive-Compulsive Disorder Drugs Market by Product
8.4.1 SSRI
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 TCA
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Others
8.5 Global Obsessive-Compulsive Disorder Drugs Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Eli Lilly and Company
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 GlaxoSmithKline plc
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 H. Lundbeck A/S
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Pfizer Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Lupin Limited
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Obsessive-Compulsive Disorder Drugs Market: Key Industry Highlights, 2018 and 2028
2. Global Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Product (USD Billion), 2018-2022
3. Global Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Product (USD Billion), 2023-2028
4. Global Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Region (USD Billion), 2018-2022
5. Global Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Region (USD Billion), 2023-2028
6. North America Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
7. North America Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
8. Europe Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
9. Europe Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
10. Asia Pacific Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
11. Asia Pacific Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Latin America Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Latin America Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Middle East and Africa Obsessive-Compulsive Disorder Drugs Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Middle East and Africa Obsessive-Compulsive Disorder Drugs Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Global Obsessive-Compulsive Disorder Drugs Market Structure
Key Questions Answered in the Report
The global obsessive-compulsive disorder drugs market is further likely to grow at a CAGR of 4.8% in the forecast period of 2023 and 2028.
The major drivers of the industry include the rising investment in the R&D and health care industry, development of new drugs to treat the obsessive-compulsive disorder, rising consumer awareness, and increased government initiatives.
The rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies are the key factors driving industry growth globally.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major products in the industry are SSRI and TCA, among others.
The key players in the industry are Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.
Analyst Review
The global market for obsessive-compulsive disorder drugs is driven by growing investment in the R&D and health care industry in recent years. Aided by the development of new drugs to treat the obsessive-compulsive disorder and rising consumer awareness, the market is projected to grow at a CAGR of 4.8% in the forecast period of 2023-2028.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product, the industry can be segmented into SSRI and TCA, among others. The major regional markets for obsessive-compulsive disorder drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER